Top Buy
| Wertpapier | Buy ▼ | Sell | Buy (1M) | Sell (1M) | Kurs | Kursziel | Potential |
|---|---|---|---|---|---|---|---|
| Eli Lilly Corp. | 54 | 0 | 6 | 0 | 830,10 € | 800,00 € | -3,63 % |
| Biogen Inc. | 50 | 1 | 4 | 0 | 208,30 € | 293,22 € | 40,77 % |
| Vertex Pharmaceuticals Inc. | 49 | 2 | 5 | 0 | 435,05 € | 428,60 € | -1,48 % |
| Regeneron Pharmaceuticals Inc. | 39 | 1 | 3 | 0 | 967,20 € | 1.006,8 € | 4,09 % |
| Alnylam Pharmace. | 36 | 0 | 0 | 0 | 143,30 € | 236,30 € | 64,90 % |
| Johnson & Johnson | 34 | 1 | 3 | 0 | 135,66 € | 187,15 € | 37,96 % |
| Cytokinetics Inc. | 33 | 1 | 7 | 0 | 48,40 € | 83,56 € | 72,65 % |
| Neurocrine Bioscience | 32 | 0 | 3 | 0 | 121,90 € | 140,87 € | 15,56 % |
| Merck & Co. Inc. | 31 | 1 | 3 | 0 | 119,20 € | 124,97 € | 4,84 % |
| Insmed Inc. | 30 | 1 | 12 | 1 | 59,50 € | 63,62 € | 6,93 % |
| Pfizer Inc. | 28 | 4 | 1 | 0 | 25,54 € | 41,10 € | 60,94 % |
| Intra-Cellular Therapies Inc. | 28 | 0 | 4 | 0 | 70,50 € | 79,68 € | 13,02 % |
| Amgen Inc. | 26 | 0 | 1 | 0 | 285,00 € | 298,90 € | 4,88 % |
| Zoetis Inc. A | 23 | 1 | 0 | 0 | 157,98 € | 200,06 € | 26,63 % |
| AbbVie Inc. | 23 | 0 | 2 | 0 | 159,60 € | 175,11 € | 9,72 % |
| TG Therapeutics Inc. | 22 | 4 | 0 | 0 | 15,63 € | 28,06 € | 79,60 % |
| Ultragenyx Pharmaceutical Inc. | 22 | 1 | 6 | 0 | 35,00 € | 85,51 € | 144,32 % |
| United Therapeutics | 21 | 0 | 3 | 0 | 285,20 € | 288,66 € | 1,21 % |
| Iovance Biotherapeutics Inc. | 21 | 3 | 2 | 0 | 7,45 € | 26,24 € | 252,35 % |
| G1 Therapeutics | 21 | 2 | 7 | 1 | 2,39 € | 10,54 € | 341,15 % |
| Sutro Biopharma Inc | 21 | 0 | 0 | 0 | 3,10 € | 11,04 € | 256,21 % |
| BioMarin Pharmaceutical Inc. | 20 | 0 | 0 | 0 | 78,30 € | 102,62 € | 31,06 % |
| EyePoint Pharmaceuticals Inc. | 19 | 1 | 1 | 0 | 8,41 € | 27,83 € | 230,77 % |
| Exelixis Inc. | 18 | 0 | 0 | 0 | 20,09 € | 26,01 € | 29,45 % |
| Halozyme Therapeutics Inc. | 18 | 0 | 4 | 0 | 46,80 € | 49,59 € | 5,95 % |